
Zydus wins US FDA nod for generic diabetes drug dapagliflozin
Dapagliflozin tablets for diabetic patients have recorded annual sales of about $10.2 billion in the US for the 12 months ended February 2026.

Dapagliflozin tablets for diabetic patients have recorded annual sales of about $10.2 billion in the US for the 12 months ended February 2026.

Pine Labs operates in a large and growing total addressable market for digital payments, and expects a compound annual growth rate of 23% to 25%…

Ashok Leyland’s growth in the truck segment was lower than the three-month average of 37%, while the light commercial vehicle (LCV) segment growth was also…

As the ceasefire brings the US-Iran war to a pause, we asked the Singapore-based fund manager for stocks that look attractive at current levels.

Iran-US ceasefire reopens Strait of Hormuz. Reports suggest that Iran may charge $2 million dollars per ship.

Earlier in February, Shriram Finance had received confirmation from the Reserve Bank of India (RBI) that Japan’s MUFG Bank does not require prior approval for…

P N Gadgil Jewellers shares rose after Q4 revenue jumped 124% to ₹3,552 crore, FY26 sales hit ₹10,744 crore, firm plans 25 new stores and…

A sustained rally in the secondary market may enthuse companies waiting to IPO. However, investors scarred by past IPOs may need more assurance.

US judge grants Gautam Adani a hearing on his bid to dismiss SEC fraud case over alleged 250 million dollar India bribery scheme, Adani disputes…

Two weeks ago, L&T had given an update regarding its 100 operating sites in the Gulf region in all segments. As much as 95% of…